| Literature DB >> 34046541 |
Komal F Satti1, Susanne E Tanski1, Yike Jiang1,2, Auden McClure1.
Abstract
Obesity affected 13.7 million children in the United States in 2015. The American Academy of Pediatrics (AAP) offers an evidence-based approach to obesity management, but adherence to recommendations is suboptimal. Our objective was to improve provider adherence to the AAP recommendations for care of patients with obesity by making systematic changes in our practice for patients of ages > 2 and younger than 19 years with a BMI > 95th percentile.Entities:
Year: 2021 PMID: 34046541 PMCID: PMC8143745 DOI: 10.1097/pq9.0000000000000412
Source DB: PubMed Journal: Pediatr Qual Saf ISSN: 2472-0054
Fig. 1.Fishbone diagram. Reasons for suboptimal care process.
Details of 5 PDSA Cycles Conducted by QI Team
| PDSA Cycle 1 January–April 2018 | |||
|---|---|---|---|
| Plan | Do | Study | Act |
| Barriers: Lack of knowledge/training, discomfort addressing obesity as identified by fishbone diagram | • Quarterly faculty meetings to provide educational material on pediatric-specific obesity | • Laboratory testing rates from 21.8% to 25%. | • When data were shared back with providers they expressed that competing priorities often led to them not follow recommendations |
| PDSA Cycle 2 April–August 2018 | |||
| Plan | Do | Study | Act |
| Barriers: Lack of prompts in the EMR to serve as reminders and lack of algorithms for screening readily available in clinics | • Provide practice support tools like the AAP algorithm for screening and management of obesity readily available in clinics and provider workspaces | • Laboratory testing rates from 25% to 34.4% | • EMR smart-list required the providers to remember to request the smart-list to populate, which was an additional step in the care process. Competing priorities and time constraints were identified as an ongoing barrier |
| PDSA Cycle 3 August–December 2018 | |||
| Plan | Do | Study | Act |
| Barriers: Time constraints and competing priorities leading to not using the smart-list when indicated. Continued discomfort with addressing obesity | • Conduct motivational interviewing workshops for the staff | Rates of counseling increased from 63.6% to 65.9% during this PDSA cycle | Providers found the MI training to be helpful |
| PDSA Cycle 4 December 2018–April 2020 | |||
| Plan | Do | Study | Act |
| Barriers: Time constraints and missed opportunities to address obesity care | • Engage the providers and staff and select practice champions to help with improvement efforts. | • Laboratory testing rates from 37.7% to 42.9% | Overall this intervention seemed to have all providers and staff excited to have some actionable items available in the clinic room to provide to families |
| PDSA Cycle 5 December 2018–April 2020 | |||
| Plan | Do | Study | Act |
| Barriers: Lack of usage of smart-list in the EMR as it required provider to request it in the note. Often times providers completed notes after the encounter which did not serve the purpose of this acting as a prompt for provider | • Implement a BPA for patients with BMI% | • Laboratory testing rates from 42.9% to 44% | Hold further PDSA cycles allowing for the current system to be more consistently adopted |
Operational Definitions of Process Measures
| Measure | Operational Definition |
|---|---|
| Obesity on problem list | Percent of eligible encounters that had obesity documented in the problem list or any other weight-related concerns in the problem list like overweight or high BMI percentile. |
| Referral | Percent of eligible encounters that were offered a referral to pediatric lipid and weight management program, nutrition or a community-based pilot program either at this visit or these orders were placed ever in the past. This was tracked by noting documentation of “referral offered” in the progress note or actual referral order noted in EHR. |
| Laboratory tests | Percent of eligible encounters that had any of the screening labs offered at this visit or done in the last 2 y. These include: (1) lipid profile; (2) ALT/AST; and (3) A1C or fasting blood glucose |
| Counseling | Percent eligible patients who had any documentation of counseling around healthy lifestyle/weight done at current visit. Any documentation of discussion endorsing healthy diet and activity will count |
| Recommended early follow-up | Percent eligible encounters where a follow-up was offered to discuss BMI percentile and obesity |
Denominator for all measures is patient encounters between ages >2 and younger than 19 years seen for preventive visit during the study period.
A1C, hemoglobin A1C; ALT, alanine aminotransferase; AST, aspartate aminotransferase; EHR, electronic health record.
Fig. 2.P-charts for all 5 measures tracked showing the proportion of eligible patient encounters that satisfied our process measures.
Percentage Compliance by Age at Baseline and Intervention Period
| Age 2 to younger than 6 years | Age 6 to younger than 13 years | Age 13 to younger than 19 years | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Intervention | Baseline | Intervention | Baseline | Intervention | ||||||||||
| n | % | n | % | n | % | n | % | n | % | n | % | ||||
| Obesity on problem list | 17 | 21.0 | 76 | 40 | 0.0025 | 95 | 50.8 | 220 | 57.9 | 0.1096 | 85 | 57.8 | 215 | 68.0 | 0.0324 |
| Recommended early follow-up | 19 | 23.5 | 16 | 8.4 | 0.0008 | 28 | 15.0 | 62 | 16.3 | 0.6892 | 61 | 41.5 | 66 | 20.9 | 0.0000 |
| Referral | 5 | 6.2 | 14 | 7.4 | 0.7263 | 38 | 20.3 | 108 | 28.4 | 0.0385 | 16 | 10.9 | 110 | 34.8 | 0.0000 |
| Laboratory tests | 5 | 6.2 | 24 | 12.6 | 0.1188 | 43 | 23.0 | 151 | 39.7 | 0.0001 | 50 | 34.0 | 160 | 50.6 | 0.0008 |
| Counseling | 45 | 55.6 | 122 | 64.2 | 0.1835 | 118 | 63.1 | 256 | 68.2 | 0.2263 | 106 | 72.1 | 222 | 70.3 | 0.6892 |
Fig. 3.BPA linked to a smart-set.